Immunotherapy and Transarterial therapy of <scp>HCC</scp> : What the interventional radiologist needs to know about the changing landscape of <scp>HCC</scp> treatment?-Reference-Cited by-同舟云学术

Immunotherapy and Transarterial therapy of HCC : What the interventional radiologist needs to know about the changing landscape of HCC treatment?

Published:2022-03-31 Issue:4 Volume:66 Page:478-482
ISSN:1754-9477
Container-title:Journal of Medical Imaging and Radiation Oncology
language:en
Short-container-title:J Med Imag Rad Onc

Author:

Tibballs Jonathan¹^ORCID,Clements Warren²³⁴^ORCID

Affiliation:

1. Department of Radiology Sir Charles Gairdner Hospital Perth Western Australia Australia

2. Department of Radiology Alfred Hospital Melbourne Victoria Australia

3. Department of Surgery Monash University Central Clinical School Melbourne Victoria Australia

4. National Trauma Research Institute Melbourne Victoria Australia

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1754-9485.13405

Reference35 articles.

1. Prognostic factors associated with survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation: an Australian multicenter cohort study;Mishra G;Hepatoma Res,2021

2. Cancer in Australia 2014: Actual incidence data from 1982 to 2011 and mortality data from 1982 to 2012 with projections to 2014

3. Hepatocellular carcinoma over three decades in Victoria, Australia: epidemiology, diagnosis and trends, 1984-2013

4. Remoteness, race and social disadvantage: disparities in hepatocellular carcinoma incidence and survival in Queensland, Australia

5. Hepatocellular carcinoma in Australia's Northern Territory: high incidence and poor outcome

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A study comparing the cost‐effectiveness of conventional and drug‐eluting transarterial chemoembolisation (cTACE and DEB‐TACE) for the treatment of hepatocellular carcinoma in an Australian public hospital;Journal of Medical Imaging and Radiation Oncology;2024-07-10

2. The extract of an herbal medicine Chebulae fructus inhibits hepatocellular carcinoma by suppressing the Apelin/APJ system;Frontiers in Pharmacology;2024-05-30

3. Radioembolization plus Immune Checkpoint Inhibitor Therapy Compared with Radioembolization plus Tyrosine Kinase Inhibitor Therapy for the Treatment of Hepatocellular Carcinoma;Journal of Vascular and Interventional Radiology;2024-05

4. Radiation Segmentectomy for the Treatment of Hepatocellular Carcinoma: A Practical Review of Evidence;Cancers;2024-02-04

5. Lineage-specific regulation of PD-1 expression in early-stage hepatocellular carcinoma following 90yttrium transarterial radioembolization – Implications in treatment outcomes;European Journal of Cancer;2024-01